The Pennant Group, Inc. (PNTG) financial statements and ratios from SEC XBRL: revenue $1.0B (TTM), net margin 3.1%, revenue growth 36.3% YoY, P/E 45.1. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (latest FY) | $947.71M |
| Revenue (TTM) | $1.0B |
| Net Margin | 3.1% |
| Operating Margin (TTM) | 5.5% |
| Net Debt / EBITDA | 2.5 |
| Revenue Growth (YoY) | 36.3% |
| EPS Growth (YoY) | 19.4% |
| FCF Growth (YoY) | 19.6% |
| P/E Ratio | 45.1 |
| EV / EBITDA | 24.7 |
| Price / Book | 3.42 |
| Price / Sales | 1.41 |
| FCF Yield | -0.3% |
| Altman Z-Score | 2.65 (grey) |
| Industry P/E (Healthcare Services) | 25.4 |
| Sector P/E (Healthcare) | 21.9 |
PNTG overview · PNTG earnings · PNTG KPIs · PNTG documents · PNTG ownership · PNTG peers
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.